HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yudai Kaneko Selected Research

iminobiotin

1/2022Antibody mimetic drug conjugate manufactured by high-yield Escherichia coli expression and non-covalent binding system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yudai Kaneko Research Topics

Disease

3COVID-19
05/2022 - 01/2022
1Fever (Fevers)
01/2022
1Neoplasms (Cancer)
01/2022
1Arthralgia (Joint Pain)
01/2022

Drug/Important Bio-Agent (IBA)

3Immunoglobulin G (IgG)IBA
05/2022 - 01/2022
2VaccinesIBA
05/2022 - 03/2022
1Proteins (Proteins, Gene)FDA Link
05/2022
1Immunoglobulin M (IgM)IBA
05/2022
1NucleoproteinsIBA
05/2022
1Immunoglobulin A (IgA)IBA
05/2022
1Neutralizing AntibodiesIBA
05/2022
1AntibodiesIBA
05/2022
1AntipyreticsIBA
01/2022
1human ERBB2 proteinIBA
01/2022
1iminobiotinIBA
01/2022
1Analgesics (Analgesic Drugs)IBA
01/2022
1Immunoconjugates (Immunoconjugate)IBA
01/2022
1silicon phthalocyanineIBA
01/2022